Methenamine Price Trend

Methenamine Prices December 2023

The price of methenamine in China for Q4 2023 reached 1025 USD/MT in December. The market in China witnessed a decline in prices, primarily influenced by the reduced pricing observed in the major exporting country, Russia. The Chinese market is currently facing a downturn, marked by an overall decrease in demand from significant exporting partners. This decline in demand has notably impacted the consumption of methenamine in various sectors including pharma, rubber, and polymer.

The price of methenamine in Russia for Q4 2023 reached 820 USD/MT in December. Limited methenamine supply in Russia results from minimal exports, leading to increased stockpiles among suppliers. The consistent decline in prices indicates that suppliers are not actively engaging in extensive accumulation, opting for prompt inventory replenishment rather than larger-scale operation. Methenamine utilization in Russia appears low, contrasting with a significant uptick in the pharma sector’s performance.

Methenamine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Methenamine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of methenamine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of methenamine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of methenamine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing methenamine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Methenamine Market Analysis

The global methenamine market size reached 788.9 Thousand Tonnes in 2023. By 2032, IMARC Group expects the market to reach 1103.5 Thousand Tonnes, at a projected CAGR of 3.80% during 2023-2032.

• The increasing prevalence of urinary tract infections (UTIs) represents one of the key factors influencing the growth of the market across the globe. According to BMC, urinary tract infection (UTI) is one of the most common infectious diseases, second to upper respiratory tract infections. More than 50% of all women in at least 12% of men experience UTI in their lifetime. This is particularly significant in demographics with higher vulnerability to UTIs, like women, the elderly, and individuals with compromised immune systems which is driving the demand for effective antiseptic treatments such as methenamine. For instance, in December 2023, the US Food and Drug Administration (FDA) approved Lyrus Life Science’s Abbreviated New Drug Application (ANDA) for ‘Methenamine Hippurate Tablets USP, 1 gram.
• The rising aging population, along with a higher risk of chronic diseases and infections, such as UTIs among the geriatric population is boosting the market growth. According to the World Health Organization (WHO) by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050 the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
• The growing use of methenamine as a long-term preventive measure in elderly patients is driving the market growth. According to BMC, on logistic regression, elderly patients (>60 years) had five times higher odds of having UTI as compared to adolescents. Female participants had almost two times higher odds of having UTI as compared to male participants at the borderline p= 0.05.
• Methenamine presents a non-antibiotic alternative for managing and preventing urinary infections with increasing concerns regarding antibiotic resistance which is facilitating the growth of the market.

Methenamine News

The report covers the latest developments, updates, and trends impacting the global methenamine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in methenamine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the methenamine price trend.

Latest developments in the methenamine industry:

• In November 2023, Bayer announced new late-breaking Kerendia (finerenone) data from FIDELITY, a prespecified pooled analysis of the Phase III FIDELIO-DKD and FIGARO-DKD trials, confirming that early albuminuria reduction in patients with chronic kidney disease (CKD) in type 2 diabetes (T2D) mediated a large proportion of the treatment effect against CKD progression.
• In February 2024, Cipla Limited received approval from the Central Drug Standard Control Organization (CDSCO) to market the novel antibiotic Plazomicin in India. Plazomicin is the new intravenous (IV) aminoglycoside indicated for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis.

Product Description

Methenamine refers to a synthetic, heterocyclic organic compound employed majorly as a urinary antiseptic with the chemical formula C6H12N4.

Methenamine functions by decomposing into formaldehyde in acidic environments like the urine, where it acts to sterilize the urinary tract by killing bacteria. This makes it effective in the treatment and prevention of urinary tract infections (UTIs).

Methenamine is often administered in the form of salts, like methenamine Hippurate or methenamine mandelate, which are taken orally. These formulations help maintain an acidic pH in the urine, enhancing the drug’s effectiveness.

The use of methenamine is particularly beneficial in managing chronic urinary infections in institutions where long-term prophylactic treatment is required. It is generally well-tolerated, but it is not suitable for treating systematic infections as its action is localized to the urine. However, methenamine should not be employed by individuals with severe liver or kidney disease without medical supervision.

Regional Coverage

The report provides a detailed analysis of the methenamine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the methenamine price trend.

Global Methenamine Price

The report offers a holistic view of the global methenamine pricing trends in the form of methenamine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of methenamine but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed methenamine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Methenamine Price

The European region in the methenamine market experienced a declining trend in prices. The product crude market's ongoing decline has impacted the costs of crucial feedstocks such as formaldehyde and ammonia. Both the pharma and chemical sectors are underperforming, both domestically and in major importing markets like China, contributing to challenges in the downstream market. The Purchasing Managers’ Index (PMI) reflects stagnant industrial activities in the market. During this quarter, the price continued to experience short buildup activities from suppliers, resulting in a lack of fresh orders and contributing to the destocking of inventories.

This analysis can be extended to include detailed methenamine price information for a comprehensive list of countries.

North America Methenamine Price

In North America, the methenamine market exhibited a notable in prices, especially in the USA influenced by factors impacting key feedstocks such as formaldehyde and ammonia in the broader crude market. In addition to the broader market trends, the methenamine supply chain in the USA witnessed a slowdown, possibly due to decreased exports or production constraints. Suppliers responded to the market dynamics by lowering ex-quotation prices, marking a trend of decline in methenamine prices during the quarter.

Specific methenamine historical data within the United States and Canada can also be provided.

Middle East and Africa Methenamine Price

The report explores the methenamine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on methenamine prices for countries can also be provided.

Asia Pacific Methenamine Price

During the fourth quarter of 2023, the methenamine market in the Asia-Pacific region witnessed a decline in prices, especially in China due to the reduced pricing observed in the major exporting country, Russia. In response to the prevailing market conditions, suppliers have adjusted their ex-quotation prices, leading to a downward trend in methenamine prices for the current quarter. Notably, there have been no recent activities for new biddings from suppliers for the fresh accumulation of inventories.

This methenamine price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Methenamine Price

The analysis of methenamine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of methenamine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting methenamine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The methenamine price charts ensure our clients remain at the forefront of the industry.